Filed 11 Dec 2025
Last verified 13 Oct 2026Offering in progress. A listing date has not been announced, and proposed terms may change.
- Indicative valuation
- $188.6M to $264.1MBasic equity value after the offering
- Price range
- $5.00 to $7.00Per share · USD
- Offering size
- $25M to $35MBase offering, before overallotment
Company overview
Starton Holdings websiteThe company uses continuous delivery of FDA-approved active ingredients. It aims to develop and bring products to market for new indications or enhanced outcomes in existing indications.
- Company country
- United States
Offering details
USD · Base offering, before overallotment
- Exchange
- Nasdaq Capital Market
- Ticker
- STA
- Shares offered
- 5,000,000
- Shares after offering
- 37,723,596